Cite
HARVARD Citation
Smith, N. et al. (2022). Oncology drugs and added benefit: insights from 3 European health technology assessment agencies on the role of efficacy endpoints. Journal of medical economics. pp. 1-6. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smith, N. et al. (2022). Oncology drugs and added benefit: insights from 3 European health technology assessment agencies on the role of efficacy endpoints. Journal of medical economics. pp. 1-6. [Online].